Article
T-cell receptor and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: understanding a hypersensitivity reaction.
Expert review of clinical immunology - 1 Jul 2012
Ko Tai-Ming, Chen Yuan-Tsong
Abstract excerpt
Ample evidence exists to support the view that drug hypersensitivity is mediated by adaptive immunity, which involves MHC-restricted drug presentation, activation and clonal expansion of T cells. The specific MHC molecules implicated in hypersensitivity have been identified; for example, HLA-B*5701 in abacavir-induced drug hypersensitivity and HLA-B*1502 in carbamazepine-induced Stevens-Johnson syndrome. However,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
